CASI - CASI Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CASI is currently covered by 1 analysts with an average price target of $12.61. This is a potential upside of $10.72 (567.2%) from yesterday's end of day stock price of $1.89.

CASI Pharmaceuticals's activity chart (see below) currently has 4 price targets and 11 ratings on display. The stock rating distribution of CASI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30% with an average time for these price targets to be met of 108.75 days.

Highest price target for CASI is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 08-Apr-2025. First documented stock forecast 22-Jun-2015.

Best performing analysts who are covering CASI - CASI Pharmaceuticals:

Justin Zelin Sean Lee Leland Gershell Swayampakula Ramakanth

Currently out of the existing stock ratings of CASI, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.11 (111.64%)

$6

1 months 2 days ago
(08-Apr-2025)

1/5 (20%)

$1.89 (89.57%)

54

Buy

$4

2 years 5 months 24 days ago
(16-Nov-2022)

1/2 (50%)

$0.72 (21.95%)

73

Buy

$12

$10.11 (534.92%)

2 years 8 months 26 days ago
(14-Aug-2022)

1/2 (50%)

$7.98 (198.51%)

308

Buy

$50

2 years 11 months 14 days ago
(26-May-2022)

0/1 (0%)

$32.3 (182.49%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CASI (CASI Pharmaceuticals) average time for price targets to be met?

On average it took 108.75 days on average for the stock forecasts to be realized with a an average price target met ratio 30

Which analyst has the current highest performing score on CASI (CASI Pharmaceuticals) with a proven track record?

JUSTIN ZELIN

Which analyst has the current lower performing score on CASI (CASI Pharmaceuticals) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CASI (CASI Pharmaceuticals)?

Justin Zelin works at BTIG and has 2 price targets and 2 ratings on CASI

Which analyst is the currently most bullish on CASI (CASI Pharmaceuticals)?

Swayampakula Ramakanth with highest potential upside - $10.11

Which analyst is the currently most reserved on CASI (CASI Pharmaceuticals)?

Justin Zelin with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?